Metabolic alterations in HIV lipodystrophy. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
Kotler
D P
DP
Columbia University College of Physicians and Surgeons, New York, USA.
D000138:Acidosis / Q000821:virology; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000821:virology; D003362:Cost-Benefit Analysis; D005947:Glucose / Q000378:metabolism; D018149:Glucose Intolerance / Q000821:virology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006949:Hyperlipidemias / Q000821:virology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000188:drug therapy / Q000378:metabolism* / Q000821:virology*; D008687:Metformin / Q000627:therapeutic use; D010020:Osteonecrosis / Q000821:virology; D017410:Practice Guidelines as Topic; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D013577:Syndrome; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D007004:Hypoglycemic Agents; D008687:Metformin; D005947:Glucose